185 related articles for article (PubMed ID: 31194968)
1. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Yang Y; Zhao Z; Xie C; Zhao Y
Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y
Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913
[TBL] [Abstract][Full Text] [Related]
4. Liposomes actively recognizing the glucose transporter GLUT
Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
[TBL] [Abstract][Full Text] [Related]
5. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting.
Zhao Z; Chen C; Xie C; Zhao Y
Chem Phys Lipids; 2020 Jan; 226():104832. PubMed ID: 31560875
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
[TBL] [Abstract][Full Text] [Related]
8. Dual-targeting liposomes with active recognition of GLUT
Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
[TBL] [Abstract][Full Text] [Related]
9. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Wang F; Chen L; Zhang R; Chen Z; Zhu L
J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
11. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC
J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202
[TBL] [Abstract][Full Text] [Related]
12. Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery.
Huang M; Pu Y; Peng Y; Fu Q; Guo L; Wu Y; Zheng Y
Bioorg Med Chem Lett; 2020 Jun; 30(12):127151. PubMed ID: 32317211
[TBL] [Abstract][Full Text] [Related]
13. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
[TBL] [Abstract][Full Text] [Related]
15. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
[TBL] [Abstract][Full Text] [Related]
17. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
18. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
Gao B; Mu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
